NASDAQ:SUPN | EBITDA Margin | SUPERNUS PHARMACEUTICALS, INC.

Complete source-backed ebitda margin history.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-318.57%
2025-12-319.96%
2025-03-316.76%
2024-12-3123.11%
2024-03-3112.25%
2023-12-3112.59%
2023-03-3116.76%
2022-12-3132.98%
2022-03-3115.30%
2021-12-3111.82%
2021-03-3115.13%
2020-12-3133.80%
2020-03-3132.37%
2019-12-3142.26%
2019-03-3131.71%
2018-12-3135.84%
2018-03-3136.60%
2017-12-3141.71%
2017-03-3131.10%
2016-12-3127.77%
2016-03-3115.96%
2015-12-3119.13%
2015-03-3112.97%
2014-12-31-80.46%
2014-03-31-146.69%
2013-12-31-108.49%
2013-03-31-12072.11%
2012-12-31-1149.86%
2012-03-31-3679.33%
2011-12-31-23847.62%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-314.07%
2024-12-3124.49%
2023-12-3113.10%
2022-12-3119.73%
2021-12-3120.46%
2020-12-3136.86%
2019-12-3139.52%
2018-12-3137.05%
2017-12-3136.61%
2016-12-3126.95%
2015-12-3115.16%
2014-12-31-4.86%
2013-12-31-529.59%
2012-12-31-2790.41%
2011-12-31-4591.91%
2010-12-31-36731.13%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.